Venus Remedies Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by PAWAN CHAUDHARY, was filed 31 May 2022.
Venus Remedies Limited: what insiders have been doing
We have very little insider data for Venus Remedies Limited so far: the most recent filing dates from 31 May 2022. With so few records, no pattern can be drawn yet. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +88.0%Entry ₹127.85 · Close at T+365 ₹240.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 126,946 shares@ ₹217.305883.0% of flowEquity SharesSEBI:92020f3d438502f2078beb2fed94958b9af065d9Canonical exit: 28 Aug 2022 (T+90)
- 600,000 shares@ ₹10.0017.0% of flowEquity SharesSEBI:3dcbc98f9480c71e6d0b945388abdb14d1435c61
- 425,000 shares@ ₹10.00100.0% of flowEquity SharesSEBI:c9e876e12ed55f7f3559f55eec25326beeecee7e
3 of 3 declarations
About Venus Remedies Limited
Venus Remedies Limited is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions in medication. It is listed on the XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
